ΕΣΠΑ 2021-2027
Institute of Chemical Biology
ICB

Search

CLOSE
Search
ICB

Achievements

  • Establishment at the Institute of Chemical Biology of the first high resolution cryogenic electron microscopy laboratory (Cryo-EM) in Southeast Europe at the National Hellenic Research Foundation, financially supported by the European Funding of ERA Chair (P. Kastritis)
  • Since July 2023 Greece became full member of the European Research Infrastructure (ESFRI) Landmark INSTRUCT https://instruct-eric.org/news/instruct-eric-new-members—greece-and-slovenia/  (Ε. Chrysina)
  • The synthetic compound ΒΝΝ27 developed at ICB by T. Calogeropoulou’s group in collaboration with the University of Crete (Α. Gravanis, Ι. Charalampopoulos) and the spin-off company of the University of Crete, BioNature, is under clinical development for diabetic retinopathy (a disease that affects about 190 million people globally), by the international pharmaceutical company Novaliq GmbH.

Participation in Societies, Boards and Committees

  • Nominated by the Ministry of Health as main contact person representing the National Hellenic Research Foundation as national competent authority for the emblematic EU4Health Joint Action “JANE-2 on Networks of Expertise on Cancer” (A. Pintzas, 2022-2024 and 2024-2028)
  • Elected vice chair of Instruct-ERIC Council (July 2025) (E. Chrysina)
  • Member of the Experts Network for “Nanotechnology in food and feed” of the European Authority for Food Safety (EFSA) (2024 to date, M. Zoumpanioti)
  • Elected member of the Board of the Hellenic Crystallographic Association (HeCrA) (2024 to date, Tsitsanou)
  • Elected General Director of the Hellenic Pasteur Institute (2021, E.S. Gonos)
  • Elected member of the Steering Committee of the Global Genomic Medicine Consortium (GGMC) (T. Katsila)
  • Elected President of the Hellenic Colloids and Interface Society (HCIS) (V. Papadimitriou)
  • Member of the International Advisory Board of the Institute for Biological Research “Siniša Stanković“, Serbia (2023 to date, E.S. Gonos)
  • Elected member of the Board of the Society for Free Radical Research-Europe-Meeting Officer (2021 to date, N. Chondrogianni)
  • Elected member of the Marketing & Outreach Committee of the Human Proteome Organization (HUPO) (T. Katsila)
  • Member of the International Evaluation Committe of the post-graduate studies of the University Tunku Abdul Rahman, Malaysia (2018-2024, E.S. Gonos)
  • Member of the Management Committee of COST Action CA21135 “IMMUNO-model” (2022-2026, T. Katsila)
  • Member of the Management Committee and Work Package leader of COST Action CA 21111 “One Health Drugs” (2022 -2026, T. Calogeropoulou)
  • Member of the Management Committee of COST Action CA 20121 “BenBedPhar: Bench to bedside transition for pharmacological regulation of Nrf2 in non-communicable diseases” (2021-2025, N. Chondrogianni)
  • Member of the Management Committee of COST Action CA 20113 “ProteoCure: A sound proteome for a sound body: targeting proteolysis for proteome remodelling” 2021-2025, Chondrogianni)
  • Member of the Board of the “European Society of Anti-Aging Medicine” (2023 to date, S. Gonos)
  • Member of the Board of the Network “Building Links in Ageing Science and Translation”, UK (2022 to date, E.S. Gonos)